National Center for Research Resources (NCRR): Cystic Fibrosis trials

The registry lists 13 Cystic Fibrosis studies with National Center for Research Resources (NCRR) as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2Phase 3 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET ImagingStatus unknownNCT00023465
• Study of Metabolic Effects of Pregnancy in Women With Cystic FibrosisTerminatedNCT00014768
• Pressure Support Ventilation During CF ExacerbationsSuspendedNCT00008775Not applicable
• Bone Health of People With Cystic FibrosisCompletedNCT00008762
• Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic FibrosisStatus unknownNCT00006273
• Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic FibrosisCompletedNCT00006063Not applicable
• Growth Hormone Use in Cystic Fibrosis - a Multicenter StudyCompletedNCT00005112Phase 3
• A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic FibrosisSuspendedNCT00005110Not applicable
• Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic FibrosisCompletedNCT00004779Phase 1
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic FibrosisCompletedNCT00004747Phase 2
• Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver DiseaseStatus unknownNCT00004315Phase 2
• Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis PatientsCompletedNCT00004296
• Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic FibrosisCompletedNCT00004287Phase 1